AtriCure to Present at the Leerink Swann 2013 Global Healthcare Conference
AtriCure to Present at the Leerink Swann 2013 Global Healthcare Conference
WEST CHESTER, Ohio--(BUSINESS WIRE)-- AtriCure, Inc. (NAS: ATRC) , a medical device company and a leader in cardiac surgical ablation systems for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage, today announced that it will present at the Leerink Swann 2013 Global Healthcare Conference at the Waldorf Astoria Hotel in New York on Thursday, February 14, 2013. Management is scheduled to present at 2:30 p.m. Eastern Time.
A live audio webcast and replay of the presentation will be available for 30 days following the presentation at www.atricure.com.
About AtriCure, Inc.
AtriCure, Inc. is a medical device company and a leader in developing, manufacturing and selling innovative cardiac surgical ablation systems designed to create precise lesions, or scars, in cardiac, or heart, tissue for the treatment of atrial fibrillation, or AF, and systems for the exclusion of the left atrial appendage. For more information, please visit www.atricure.com.
AtriCure, Inc.
Andy Wade, 513-755-4564
Vice President and Chief Financial Officer
awade@atricure.com
or
Investor Relations Contact:
Westwicke Partners
Lynn Pieper, 415-202-5678
Lynn.pieper@westwicke.com
KEYWORDS: United States North America New York Ohio
INDUSTRY KEYWORDS:
The article AtriCure to Present at the Leerink Swann 2013 Global Healthcare Conference originally appeared on Fool.com.
Try any of our Foolish newsletter services free for 30 days. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy.
Copyright © 1995 - 2013 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.
